Researchers present phase I data for neoadjuvant anti-OX40 therapy with MEDI-6469 in HNSCC June 14, 2018
Seattle Genetics doses first patient in phase II study of tisotumab vedotin for cervical cancer June 14, 2018
vTv reports Part B results from STEADFAST study of azeliragon in mild Alzheimer's disease June 14, 2018
Tyme reports detailed data from first-in-human study and compassionate use program of SM-88 June 13, 2018
RSS